Coming Soon: Novavax COVID-19 Vaccine Authorization

Effective for dates of service on or after July 13, 2022, the U.S. Food and Drug Administration (FDA) amended the Emergency Use Authorizations (EUAs) for the Novavax COVID-19 vaccine for the prevention of COVID-19 for individuals 18 years of age and older. The Department of Health Care Services is aggressively pursuing the necessary system and operational changes required to enable successful claims adjudication for administration of the Novavax COVID-19 vaccine.

Medi-Cal will announce when the claims adjudication system is prepared to appropriately adjudicate submitted claims, as well as any additional instruction providers should utilize when billing for the Novavax COVID-19 vaccine in a future Medi-Cal update.

For the most current information regarding Medi-Cal’s COVID-19 response, see the page COVID-19 Medi-Cal Response on the Medi-Cal Providers website.